<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>2</title>
<title_fa>1</title_fa>
<short_title>3</short_title>
<subject>Literature &amp; Humanities</subject>
<web_url>http://idai.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>9</journal_id_issn>
<journal_id_issn_online>10</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>7</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>fa</language>
<pubdate>
	<type>jalali</type>
	<year>1390</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2012</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>3</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa>HPV oral lesions in HIV-infected patients: the impact of long-term HAART</title_fa>
	<title></title>
	<subject_fa>بیماری های دهان</subject_fa>
	<subject>Oral Medicine</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa>&lt;p&gt; &lt;strong&gt;Background&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;  Since the introduction of highly active antiretroviral therapy (HAART), an increase in the frequency of human papillomavirus-associated oral lesions (HPV-OL) has been observed. Thus, the aim of this study was to determine the prevalence and factors associated with HPV-OL in Mexican HIV-infected patients, as well as its genotyping, in the HAART era. &lt;/p&gt;&lt;p&gt; &lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;  In a cross-sectional study developed at an HIV/AIDS referral center in Mexico City, HIV-infected patients were consecutively included from 2004 to 2011. An oral exam was performed lymphocyte CD4+ count, HIV-viral load, CDC-stage, and HAART use were recorded. HPV-OL samples were taken for routine histopathological analysis (H-E) and HPV-DNA amplification/sequencing. Logistic regression models were performed and the interactions tested using the STATA software. &lt;/p&gt;&lt;p&gt; &lt;strong&gt;Results&lt;/strong&gt; &lt;/p&gt;&lt;p&gt; Among 787 HIV patients, 55 (6.9%) showed HPV-OL. HPV-OLs were independently associated with age (≥40 years) and with a longer time of HAART use (≥12 months). The most frequent lesion was squamous cell papilloma in 22 (40%) cases, followed by multifocal epithelial hyperplasia in 15 (27.3%) cases. Labial mucosa was the most common site involved (56.4%). Of the sequences obtained, 65.4% corresponded to low risk and 11.5% to high risk. Mixed high- and low-risk infection were identified in 7.7% of the cases. &lt;/p&gt;&lt;p&gt; &lt;strong&gt;Conclusions&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;  Human papillomavirus-associated oral lesions were associated with older age and longer HAART use. All lesions were benign in nature and most of the HPV sequences corresponded to low-risk types. The rise of HPV-OLs in HIV patients on HAART may be related with the longer life expectancy of individuals with an impaired immune system rather than a direct effect of HAART. &lt;/p&gt;&lt;hr&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Source: &lt;/strong&gt;Journal of Oral Pathology &amp; Medicine&lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://onlinelibrary.wiley.com/doi/10.1111/jop.12032/abstract&quot; target=&quot;_blank&quot;&gt;&lt;font color=&quot;#0000ff&quot;&gt; Full Text&lt;/font&gt;&lt;/a&gt;&lt;/p&gt;</abstract_fa>
	<abstract></abstract>
	<keyword_fa>HAART ;human papillomavirus;oral warts</keyword_fa>
	<keyword></keyword>
	<start_page>0</start_page>
	<end_page>0</end_page>
	<web_url>http://idai.ir/browse.php?a_code=A-10-32-2271&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Gabriela</first_name>
	<middle_name></middle_name>
	<last_name>Anaya-Saavedra</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460010755</code>
	<orcid>100319475328460010755</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Universidad Autónoma Metropolitana-Xochimilco, Ciudad de México, Mexico</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Bertha</first_name>
	<middle_name></middle_name>
	<last_name>Flores-Moreno</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460010756</code>
	<orcid>100319475328460010756</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Universidad Autónoma Metropolitana-Xochimilco, Ciudad de México, Mexico</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Alejandro </first_name>
	<middle_name></middle_name>
	<last_name>García-Carrancá</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460010757</code>
	<orcid>100319475328460010757</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Instituto Nacional de Cancerología (INCan), Ciudad de México, Mexico/Unidad de Virus y Cáncer, Instituto de Investigaciones Biomédicas, UNAM, Ciudad de México, Mexico</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Esther</first_name>
	<middle_name></middle_name>
	<last_name> Irigoyen-Camacho</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460010758</code>
	<orcid>100319475328460010758</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Universidad Autónoma Metropolitana-Xochimilco, Ciudad de México, Mexico</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Miriam </first_name>
	<middle_name></middle_name>
	<last_name>Guido-Jiménez</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460010759</code>
	<orcid>100319475328460010759</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Instituto Nacional de Cancerología (INCan), Ciudad de México, Mexico/Unidad de Virus y Cáncer, Instituto de Investigaciones Biomédicas, UNAM, Ciudad de México, Mexico</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Velia</first_name>
	<middle_name></middle_name>
	<last_name>Ramírez-Amador</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>rava1863@correo.xoc.uam.mx</email>
	<code>100319475328460010760</code>
	<orcid>100319475328460010760</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Universidad Autónoma Metropolitana-Xochimilco, Ciudad de México, Mexico</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
